• FirefoxInstall the new Firefox »
  •  Dow Up 0.19% Nasdaq Up 0.57%

    Celgene Corporation (CELG)

    -NasdaqGS
    118.68 Up 1.02(0.87%) Mar 27, 4:00PM EDT
    |After Hours : 118.51 Down 0.17 (0.14%) Mar 27, 7:56PM EDT
    Add to Portfolio
    Prev Close:117.66
    Open:118.11
    Bid:118.50 x 100
    Ask:118.89 x 1000
    1y Target Est:138.43
    Beta:1.77
    Earnings Date:Apr 22 - Apr 27 (Est.)
    Day's Range:118.02 - 120.00
    52wk Range:66.85 - 129.06
    Volume:5,510,401
    Avg Vol (3m):5,397,220
    Market Cap:95.01B
    P/E (ttm):49.66
    EPS (ttm):2.39
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 0.87%95.01B
    JNJUp 0.20%278.99B

    Key Statistics

    Forward P/E (1 yr):18.75
    P/S (ttm):12.28
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :4.82
    Quarterly EPS Est (Mar-15) :1.06
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.96

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and inflammatory diseases in the United States and Internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback